X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (10) 10
index medicus (10) 10
acute promyelocytic leukemia (7) 7
chemotherapy (7) 7
oncology (6) 6
atra (5) 5
risk-adapted treatment (5) 5
trans-retinoic acid (5) 5
arsenic trioxide (4) 4
further section (4) 4
humans (4) 4
prognostic (4) 4
prognostic-factors (4) 4
relapse (4) 4
anthracycline (3) 3
anthracycline monochemotherapy (3) 3
diagnosis (3) 3
risk (3) 3
additional chromosome-abnormalities (2) 2
adult (2) 2
cd56 (2) 2
complex karyotype (2) 2
consolidation (2) 2
consolidation therapy (2) 2
cytogenetic changes (2) 2
early death rate (2) 2
failure (2) 2
flt3 mutations (2) 2
indicator (2) 2
janus kinase 2 - genetics (2) 2
janus kinase 2 - metabolism (2) 2
myelofibrosis (2) 2
myeloproliferative disorders - enzymology (2) 2
outcome (2) 2
pethema (2) 2
phenylalanine - genetics (2) 2
polycythemia-vera (2) 2
prognostic-significance (2) 2
risk factors (2) 2
valine - genetics (2) 2
1st-line treatment (1) 1
617v-greater-than-f mutation (1) 1
acute myeloid-leukemia (1) 1
acute promyeloid leukemia (1) 1
agnogenic myeloid metaplasia (1) 1
aida protocol (1) 1
allele burden (1) 1
allele-specific pcr (1) 1
amino acid substitution (1) 1
aml (1) 1
animals (1) 1
antibiotics (1) 1
antibody (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineuronal antibodies (1) 1
apl prognostic factors (1) 1
apl real life outcomes (1) 1
apoptosis (1) 1
atomic force microscopy (1) 1
biomechanics (1) 1
blood (1) 1
body mass index (1) 1
body weight (1) 1
bone-marrow-transplantation (1) 1
boronic acids - therapeutic use (1) 1
bortezomib (1) 1
brief communication (1) 1
busulfan (1) 1
calibration (1) 1
castleman disease - complications (1) 1
castleman disease - drug therapy (1) 1
castleman disease - pathology (1) 1
cell (1) 1
cell line (1) 1
cell nuclei stiffness (1) 1
cells (1) 1
ceramic material (1) 1
characteristics (1) 1
chemical bonds (1) 1
chromatin (1) 1
clam (1) 1
clinical outcome (1) 1
coexistence of neoplasms (1) 1
colony-forming units assay (1) 1
competing risks (1) 1
conditioning (1) 1
cord blood transplantation (1) 1
criminal law (1) 1
daunorubicin (1) 1
deoxyribonucleic acid--dna (1) 1
differentiation syndrome (1) 1
disease (1) 1
dna - genetics (1) 1
dna damage (1) 1
dna stiffness (1) 1
dna structural changes (1) 1
dna structure (1) 1
donors (1) 1
doxorubicin (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 01/2009, Volume 94, Issue 1, pp. 38 - 45
Journal Article
BONE MARROW TRANSPLANTATION, ISSN 0268-3369, 01/2020, Volume 55, Issue 1, pp. 147 - 156
... Danylesko1 ● Noga Shem Tov1 ● Ronit Yerushalmi1 ● Marta Sobas3 ● Anna Czyż 3 ● Arnon Nagler1 ● Avichai Shimoni1 Received: 5 July 2019 / Revised: 6 August 2019 / Accepted... 
SURVIVAL | SINGLE | BONE-MARROW-TRANSPLANTATION | IMMUNOLOGY | RUXOLITINIB | TRANSPLANTATION | CORD BLOOD TRANSPLANTATION | WORKING GROUP | OLDER PATIENTS | ONCOLOGY | AGNOGENIC MYELOID METAPLASIA | LEUKEMIA | NON-RELAPSE MORTALITY | HEMATOLOGY | Fludarabine | Myelofibrosis | Donors | Stem cells | Health hazards | Stem cell transplantation | Transplantation | Histocompatibility antigen HLA | Busulfan | Conditioning | Hematopoietic stem cells | Hemopoiesis
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5422 - 5422
Background: Since several decades, the outcome of patients with lymphoma has improved. Unfortunately, because of that, the risk of therapy-related secondary... 
Journal Article
Clinical lymphoma, myeloma and leukemia, ISSN 2152-2650, 09/2018, Volume 18, p. S265
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4180 - 4180
Background: Ruxolitinib (RUX), an inhibitor of JAK1/JAK2 kinases, is the only drug approved for the treatment of myelofibrosis (MF). The main clinical effects... 
Journal Article
Leukemia, ISSN 0887-6924, 02/2020
Data on outcome in older (≥70 years) patients with acute promyelocytic leukemia after treatment with arsenic trioxide (ATO) compared with standard chemotherapy... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 80 - 80
Abstract Background: Characteristics and outcome of older patients (pts) with acute promyelocytic leukemia (APL) are unclear due to lack of clinical data.... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.